Newfund | HEKA
◆ Fund Size
$151.9M
◆ Check Size
◆ Location
France
◆ Portfolio
5 companies
◆ Activity
Statusactively investing
◆ Links
◆ Share this fund
◆ Investment Thesis
To promote European innovation in BrainTech and finance technology startups focused on brain health in response to U.S. dominance and untapped European potential.
◆ About Newfund
HEKA is the first European technology fund dedicated exclusively to BrainTech and neuroscience innovation. The fund supports companies developing solutions in neurology, psychiatry, and cognitive health through AI, digital therapeutics, advanced imaging, and next-generation biotechnologies. Newfund combines capital deployment with operational support to help founders navigate clinical validation, regulatory pathways, and U.S. commercialization.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Anne-Sophie Saint-Martin | Partner | — | |
| François Véron | General Partner / Managing Partner | — | |
| Henri Deshays | General Partner | — | |
| Patrick Malka | General Partner | — | |
| Salim Hassad | Partner | — |
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does HEKA invest in?
HEKA invests in Biotech, Digital Health, Medtech, Mental Health and Diagnostics at the seed and series-a stages.
Which geographies does HEKA focus on?
HEKA focuses on Europe, and is headquartered in France.
What is HEKA's typical check size?
HEKA typically writes checks of $0.1M to $1M.